EyePoint, Inc. (EYPT)
13.10
-0.25
(-1.87%)
USD |
NASDAQ |
May 27, 14:56
EyePoint Free Cash Flow : -271.54M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Ocular Therapeutix, Inc. | -240.94M |
| Edgewise Therapeutics, Inc. | -148.96M |
| Merck & Co., Inc. | 14.12B |
| Bristol Myers Squibb Co. | 11.91B |
| Arvinas, Inc. | -256.90M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -80.55M |
| Cash from Investing (Quarterly) | 59.05M |
| Cash from Financing (Quarterly) | -2.614M |
| Free Cash Flow Per Share (Quarterly) | -0.9482 |
| Free Cash Flow to Equity (Quarterly) | -81.07M |
| Free Cash Flow to Firm (Quarterly) | -81.55M |
| Free Cash Flow Yield | -26.82% |